Molecular insights into neurodevelopmental and neurodegenerative diseases

被引:21
作者
Pettegrew, JW
Klunk, WE
Panchalingam, K
McClure, RJ
Stanley, JA
机构
[1] Univ Pittsburgh, Sch Med, Neurophys Lab, Dept Psychiat, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Sch Med, Neurophys Lab, Dept Neurol, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Sch Med, Neurophys Lab, Dept Hlth Serv Adm, Pittsburgh, PA 15213 USA
关键词
magnetic resonance spectroscopy; Alzheimer's disease; neurodevelopment;
D O I
10.1016/S0361-9230(00)00376-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Magnetic resonance spectroscopy (MRS) is a noninvasive physical technique that is routinely used to determine the quantity and structure of organic molecules in solution, Technical advances that have expanded the usefulness of this technique include: (1) high resolution MRS to identify and quantify individual molecules present in complex mixtures of tissue extracts; (2) in vivo MRS techniques to non-invasively monitor metabolites in humans; (3) stucture determination of proteins of moderate size; and (4) improved structure characterization of solids and liquid crystals, such as the detection of phase changes in membranes. The focus of this review is on the first two technical advances mentioned above. The strengths of MRS as a research tool to investigate molecular alterations in disease states include ease of sample preparation, minimum sample manipulation, avoidance of the preparation of derivatives, and the ability to analyze an unfractionated sample. The strengths of MRS in the clinic are its ability to measure neuronal metabolite levels non-invasively in humans and its potential for disease diagnosis, monitoring disease progression, and assessing the efficacy of experimental therapies. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:455 / 469
页数:15
相关论文
共 110 条
  • [1] Araujo D M, 1989, Prog Clin Biol Res, V317, P423
  • [2] CHANGES IN ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE IN ALZHEIMERS-DISEASE RESEMBLE EMBRYONIC-DEVELOPMENT - A STUDY OF MOLECULAR-FORMS
    ARENDT, T
    BRUCKNER, MK
    LANGE, M
    BIGL, V
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1992, 21 (03) : 381 - 396
  • [3] WOMEN, MYOCARDIAL-INFARCTION, AND DEMENTIA IN THE VERY OLD
    ARONSON, MK
    OOI, WL
    MORGENSTERN, H
    HAFNER, A
    MASUR, D
    CRYSTAL, H
    FRISHMAN, WH
    FISHER, D
    KATZMAN, R
    [J]. NEUROLOGY, 1990, 40 (07) : 1102 - 1106
  • [4] AGING BRAIN - EFFECT OF ACETYL-L-CARNITINE TREATMENT ON RAT-BRAIN ENERGY AND PHOSPHOLIPID-METABOLISM - A STUDY BY P-31 AND H-1-NMR SPECTROSCOPY
    AURELI, T
    MICCHELI, A
    RICCIOLINI, R
    DICOCCO, ME
    RAMACCI, MT
    ANGELUCCI, L
    GHIRARDI, O
    CONTI, F
    [J]. BRAIN RESEARCH, 1990, 526 (01) : 108 - 112
  • [5] BARANY M, 1985, LANCET, V1, P517
  • [6] SOLUTION STRUCTURES OF BETA PEPTIDE AND ITS CONSTITUENT FRAGMENTS - RELATION TO AMYLOID DEPOSITION
    BARROW, CJ
    ZAGORSKI, MG
    [J]. SCIENCE, 1991, 253 (5016) : 179 - 182
  • [7] LEVELS OF PHOSPHOLIPID CATABOLIC INTERMEDIATES, GLYCEROPHOSPHOCHOLINE AND GLYCEROPHOSPHOETHANOLAMINE, ARE ELEVATED IN BRAINS OF ALZHEIMERS-DISEASE BUT NOT OF DOWNS-SYNDROME PATIENTS
    BLUSZTAJN, JK
    GONZALEZCOVIELLA, IL
    LOGUE, M
    GROWDON, JH
    WURTMAN, RJ
    [J]. BRAIN RESEARCH, 1990, 536 (1-2) : 240 - 244
  • [8] BOLINGER L, 1992, BIOL MAGN RESON, V11, P1
  • [9] BOSMAN GJCGM, 1991, GERONTOLOGY, V37, P95
  • [10] ALZHEIMER DEMENTIA - QUANTIFICATION OF ENERGY-METABOLISM AND MOBILE PHOSPHOESTERS WITH P-31 NMR-SPECTROSCOPY
    BOTTOMLEY, PA
    COUSINS, JP
    PENDREY, DL
    WAGLE, WA
    HARDY, CJ
    EAMES, FA
    MCCAFFREY, RJ
    THOMPSON, DA
    [J]. RADIOLOGY, 1992, 183 (03) : 695 - 699